最终目的地 - 药剂师对辅助自杀的看法 (PAS研究):一个横截面的融合平行混合方法研究
Stephanie Clemens1,2, Maximilian Lombardini1, Alina Braunstein1
1Institute of Pharmacy, Pharmaceutical Biology & Clinical Pharmacy, Paracelsus Medical University, Salzburg, Austria.
Journal of pharmaceutical policy and practice
|January 12, 2026
概括
奥地利的药剂师对辅助自杀有不同的看法,超过一半的药剂师使用致命药物. 关键的挑战包括情绪紧张和安全问题,强调需要更好的支持和沟通.
科学领域:
- 医学伦理 医学伦理
- 制药实践 制药实践 制药实践
- 在生命末期的护理.
背景情况:
- 协助自杀在全球范围内引起了争论,因为它使绝症患者能够有尊严的生命终结选择.
- 药剂师起着至关重要的作用,通常是与患者互动的最终医疗保健专业人员.
- 这项研究调查了奥地利药剂师对辅助自杀的看法,确定了挑战和改进策略.
研究的目的:
- 探索奥地利药剂师对辅助自杀的态度和经验.
- 确定影响药剂师参与辅助自杀的障碍和促进因素.
- 制定战略,以加强终身护理的支持和沟通.
主要方法:
- 采用了横截面融合并行混合方法研究设计.
- 通过324名药剂师的数字调查收集的定量数据 (5.11%的响应率).
- 通过使用Mayring的内容分析分析,与经验丰富的药剂师进行半结构面试 (n=5) 的定性数据.
主要成果:
- 超过一半的注册药剂师 (52.8%) 分发致命药物,认为这是一个责任.
- 非注册药剂师 (42%) 由于安全和心理负担的担忧,反对参与.
- 患者和药剂师都明显表现出了情绪上的压力;年长的药剂师感到更有准备.
结论:
- 确定了改善终身护理和药剂师参与协助自杀的关键领域.
- 建议框架,以支持药剂师协助患者,并促进自我反思.
- 强调需要改善有关协助自杀的药剂师的沟通和支持系统.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
182
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
182
Drug Dosing: Geriatric Patients
217
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
217
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
218
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
218
Analysis of Population Pharmacokinetic Data
669
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
669
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
229
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
229
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
624
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
624

